Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
14006 | 735 | 42.5 | 78% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
348 | 16958 | DNA METHYLATION//EPIGENETICS//HISTONE DEACETYLASE INHIBITOR |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | ZEBULARINE | Author keyword | 38 | 63% | 5% | 38 |
2 | DECITABINE | Author keyword | 28 | 29% | 11% | 80 |
3 | FAZARABINE | Author keyword | 24 | 91% | 1% | 10 |
4 | 5 AZA 2 DEOXYCYTIDINE | Author keyword | 16 | 24% | 8% | 60 |
5 | 2 DEOXY 5 AZACYTIDINE | Author keyword | 6 | 100% | 1% | 4 |
6 | DEMETHYLATING AGENT | Author keyword | 5 | 63% | 1% | 5 |
7 | 5 AZA 2 DEOXYCYTIDINE | Author keyword | 4 | 23% | 2% | 16 |
8 | DNMTI | Author keyword | 3 | 60% | 0% | 3 |
9 | 5 AZA 2 DEOXYCYTIDINE 5 AZA CDR | Author keyword | 2 | 67% | 0% | 2 |
10 | ARA AC | Author keyword | 2 | 67% | 0% | 2 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | ZEBULARINE | 38 | 63% | 5% | 38 | Search ZEBULARINE | Search ZEBULARINE |
2 | DECITABINE | 28 | 29% | 11% | 80 | Search DECITABINE | Search DECITABINE |
3 | FAZARABINE | 24 | 91% | 1% | 10 | Search FAZARABINE | Search FAZARABINE |
4 | 5 AZA 2 DEOXYCYTIDINE | 16 | 24% | 8% | 60 | Search 5+AZA+2++DEOXYCYTIDINE | Search 5+AZA+2++DEOXYCYTIDINE |
5 | 2 DEOXY 5 AZACYTIDINE | 6 | 100% | 1% | 4 | Search 2+DEOXY+5+AZACYTIDINE | Search 2+DEOXY+5+AZACYTIDINE |
6 | DEMETHYLATING AGENT | 5 | 63% | 1% | 5 | Search DEMETHYLATING+AGENT | Search DEMETHYLATING+AGENT |
7 | 5 AZA 2 DEOXYCYTIDINE | 4 | 23% | 2% | 16 | Search 5+AZA+2+DEOXYCYTIDINE | Search 5+AZA+2+DEOXYCYTIDINE |
8 | DNMTI | 3 | 60% | 0% | 3 | Search DNMTI | Search DNMTI |
9 | 5 AZA 2 DEOXYCYTIDINE 5 AZA CDR | 2 | 67% | 0% | 2 | Search 5+AZA+2++DEOXYCYTIDINE+5+AZA+CDR | Search 5+AZA+2++DEOXYCYTIDINE+5+AZA+CDR |
10 | ARA AC | 2 | 67% | 0% | 2 | Search ARA+AC | Search ARA+AC |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | HYPOMETHYLATING AGENT | 37 | 57% | 6% | 44 |
2 | 5 AZA 2 DEOXYCYTIDINE | 28 | 23% | 15% | 109 |
3 | 5 AZA 2 DEOXYCYTIDINE DECITABINE | 26 | 39% | 7% | 52 |
4 | DNA HYPOMETHYLATING AGENT | 17 | 68% | 2% | 15 |
5 | CISPLATIN PLUS DECITABINE | 15 | 71% | 2% | 12 |
6 | LOW DOSE 5 AZA 2 DEOXYCYTIDINE | 15 | 40% | 4% | 29 |
7 | AGENT 5 AZA 2 DEOXYCYTIDINE | 13 | 80% | 1% | 8 |
8 | DNA METHYLATION INHIBITOR | 12 | 75% | 1% | 9 |
9 | DECITABINE | 12 | 22% | 7% | 49 |
10 | ARABINOSYL 5 AZACYTOSINE | 10 | 73% | 1% | 8 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Pharmacokinetic and pharmacodynamic analysis of 5-aza-2 '-deoxycytidine (decitabine) in the design of its dose-schedule for cancer therapy | 2013 | 31 | 134 | 46% |
DNA Methyltransferase Inhibitors and Their Emerging Role in Epigenetic Therapy of Cancer | 2013 | 20 | 49 | 57% |
DNA methyltransferase inhibitors and the development of epigenetic cancer therapies | 2005 | 219 | 77 | 35% |
Decitabine: a promising epi-immunotherapeutic agent in solid tumors | 2015 | 1 | 136 | 28% |
Decitabine, a new star in epigenetic therapy: the clinical application and biological mechanism in solid tumors | 2014 | 5 | 46 | 50% |
The promises and pitfalls of epigenetic therapies in solid tumours | 2009 | 47 | 40 | 45% |
Evolution of decitabine development - Accomplishments, ongoing investigations, and future strategies | 2008 | 66 | 55 | 49% |
Epigenetic therapy of cancer with 5-aza-2 '-deoxycytidine (decitabine) | 2005 | 88 | 53 | 53% |
Changes in DNA methylation in neoplasia: Pathophysiology and therapeutic implications | 2001 | 248 | 88 | 36% |
DNA methylation inhibitor 5-aza-2 '-deoxycytidine induces reversible genome-wide DNA damage that is distinctly influenced by DNA methyltransferases 1 and 3B | 2008 | 126 | 99 | 25% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | LEUKEMIA EXPT THER EUT | 2 | 67% | 0.3% | 2 |
2 | TRANSLAT CYT GRP | 2 | 67% | 0.3% | 2 |
3 | RECH PEDIAT | 2 | 18% | 1.4% | 10 |
4 | CRUK BEATSON S | 1 | 29% | 0.5% | 4 |
5 | ADV DEV THER EUT TRAINING PROGRAM | 1 | 50% | 0.1% | 1 |
6 | ARIZONA P SCI | 1 | 50% | 0.1% | 1 |
7 | BIOMARKERS EXPT THER EUT CANC | 1 | 50% | 0.1% | 1 |
8 | DIPARTIMENTO BIOL CELLULAIRE SVILUPPO | 1 | 50% | 0.1% | 1 |
9 | EPIGENOM CANC RISK | 1 | 50% | 0.1% | 1 |
10 | FARM GARDEN ENGN | 1 | 50% | 0.1% | 1 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000210314 | DNMT3B//DNA METHYLTRANSFERASE//DNMT1 |
2 | 0.0000149959 | CYTIDINE DEAMINASE//ANTIBIOTIC FUNGICIDE//BLASTICIDIN S DEAMINASE |
3 | 0.0000148538 | RRBS//CPG ISLANDS//METHYLTRANSFERASE ACTIVITY |
4 | 0.0000142401 | DNA 5 METHYLCYTOSINE//DNA METHYLASE//5 METHYLDCMP DEAMINASE |
5 | 0.0000132988 | PHARMACOEPIGENETICS//ALFRED MED EDUC PROJECT//BANDUNG HOSP |
6 | 0.0000124843 | MIR 1260B//NOUVEL HOP ESTAING//DIETARY COMPOUNDS |
7 | 0.0000115715 | PARAMETER TG ALPHA//PARTITION ADSORPTION SYSTEMS//5 AZAPYRIMIDINES |
8 | 0.0000096229 | MYELODYSPLASTIC SYNDROMES//MYELODYSPLASTIC SYNDROME//AZACITIDINE |
9 | 0.0000096077 | CYCLOPENTENYL CYTOSINE//CTP SYNTHASE//CTP SYNTHETASE |
10 | 0.0000092044 | HISTONE DEACETYLASE INHIBITOR//HISTONE DEACETYLASE INHIBITORS//HISTONE DEACETYLASE |